Caption Management’s Boston Scientific BSX Stock Holding History

Caption Management’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$54.9M	Buy	875,000 +459,200	+110%	+$36.7M	0.32%	64
2025 Q4	$39.6M	Sell	415,800 -62,900	-13%	-$6.17M	0.27%	82
2025 Q3	$46.7M	Buy	478,700 +442,700	+1,230%	+$45.8M	0.36%	50
2025 Q2	$3.87M	Buy	+36,000	New	+$3.64M	0.04%	478
2025 Q1	–	Sell	-35,000	Closed	-$3.13M	–	1553
2024 Q4	$3.13M	Buy	+35,000	New	+$3.08M	0.03%	537
2024 Q3	–	Sell	-65,000	Closed	-$5.01M	–	1292
2024 Q2	$5.01M	Buy	+65,000	New	+$4.76M	0.08%	257
2023 Q2	–	Sell	-125,000	Closed	-$6.25M	–	1118
2023 Q1	$6.25M	Buy	+125,000	New	+$5.89M	0.12%	195
2022 Q2	–	Sell	-200,000	Closed	-$8.86M	–	1479
2022 Q1	$8.86M	Buy	+200,000	New	+$8.67M	0.11%	257
2020 Q1	–	Sell	-156,300	Closed	-$7.07M	–	870
2019 Q4	$7.07M	Buy	+156,300	New	+$6.54M	0.24%	103
2019 Q1	–	Sell	-70,000	Closed	-$2.47M	–	577
2018 Q4	$2.47M	Buy	70,000 +30,000	+75%	+$1.09M	0.2%	152
2018 Q3	$1.54M	Buy	+40,000	New	+$1.4M	0.08%	277

Other funds holding BSX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Caption Management's BSX Position: Q1 2026 in Review

Caption Management increased its Boston Scientific (BSX) stake by 311% in Q1 2026, buying an estimated $22.7M and bringing the position to 374,400 shares worth $23.5M. The position accounts for 0.14% of the portfolio, ranked #150.

Caption Management first reported a position in BSX in Q4 2018 and has held it in 10 quarters since. 1,664 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

Caption Management held 374,400 shares of Boston Scientific worth $23.5M as of Q1 2026.
Caption Management bought 283,400 Boston Scientific shares in Q1 2026, an estimated $22.7M.
Boston Scientific made up 0.14% of Caption Management's portfolio in Q1 2026, its #150 holding.
Caption Management first reported a position in Boston Scientific in Q4 2018 and has held it in 10 quarters since.
1,664 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Caption Management's 13F filing for Q1 2026, filed 15 May 2026.